Literature DB >> 31365782

MiR-424 prevents astrogliosis after cerebral ischemia/reperfusion in elderly mice by enhancing repressive H3K27me3 via NFIA/DNMT1 signaling.

Haiping Zhao1,2, Guangwen Li1, Rongliang Wang1,2, Zhen Tao1,2, Sijia Zhang1, Fangfang Li1, Ziping Han1, Lingzhi Li1, Ping Liu1, Yumin Luo1,2,3.   

Abstract

Global DNA and histone methylation patterns in astrocytes following ischemia are influenced by age; however, it is unknown whether aberrant methylation can induce reactive astrogliosis after ischemic stroke in elderly rodents. Here we showed that phosphorylated signal transducer and activator of transcription 3 (STAT3) level increased along with that of the astrogliosis marker glial fibrillary acidic protein (GFAP) on days 1, 3, and 14 post-reperfusion in 9-month-old male mice with middle cerebral artery occlusion (MCAO). Methylation of the STAT3 binding site in the GFAP gene promoter was increased in these mice on days 3 and 14 postreperfusion. The repressive modification histone 3 lysine 27 trimethylation (H3K27me3) was decreased, whereas the permissive modification histone 3 lysine 4 trimethylation was increased in GFAP-positive cells in the ipsilateral cortex. Furthermore, DNA methyltransferase 1 (DNMT1) expression in astrocytes was upregulated in the ischemic brain. In primary astrocyte cultures, the microRNA miR-424 was found to target nuclear factor IA (NFIA); miR-424 agomir increased DNMT1 and H3K27me3 levels in U87 cells subjected to oxygen and glucose deprivation and induced cell cycle arrest in primary astrocytes while suppressing reactive astrocytosis, thereby preserving the structure of neurons and their axons in MCAO mice. These results demonstrate that miR-424 prevents astrogliosis following cerebral ischemia/reperfusion in elderly mice by enhancing H3K27me3 via NFIA/DNMT1 signaling.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  DNMT1; H3K27me3; NFIA; ischemic stroke; miR-424; reactive astrogliosis

Year:  2019        PMID: 31365782     DOI: 10.1111/febs.15029

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  6 in total

Review 1.  Epigenetic mechanisms and potential therapeutic targets in stroke.

Authors:  Kahlilia C Morris-Blanco; Anil K Chokkalla; Vijay Arruri; Soomin Jeong; Samantha M Probelsky; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-19       Impact factor: 6.960

Review 2.  The progress of research on histone methylation in ischemic stroke pathogenesis.

Authors:  Yaxin Su; Lei Zhang; Yao Zhou; Lei Ding; Li Li; Zhongcheng Wang
Journal:  J Physiol Biochem       Date:  2021-09-02       Impact factor: 4.158

3.  MiR-29a Knockout Aggravates Neurological Damage by Pre-polarizing M1 Microglia in Experimental Rat Models of Acute Stroke.

Authors:  Fangfang Zhao; Haiping Zhao; Junfen Fan; Rongliang Wang; Ziping Han; Zhen Tao; Yangmin Zheng; Feng Yan; Yuyou Huang; Lei Yu; Xu Zhang; Lianfeng Zhang; Yumin Luo; Yuanwu Ma
Journal:  Front Genet       Date:  2021-03-15       Impact factor: 4.599

Review 4.  Sex-Specific MicroRNAs in Neurovascular Units in Ischemic Stroke.

Authors:  Barend W Florijn; Roel Bijkerk; Nyika D Kruyt; Anton Jan van Zonneveld; Marieke J H Wermer
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

5.  ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI.

Authors:  Qi Shi; Nana Feng; Qingyun Ma; Shaohua Wang; Huijun Zhang; Dayu Huang; Jiayuan Sun; Meng Shi
Journal:  Oxid Med Cell Longev       Date:  2022-07-19       Impact factor: 7.310

6.  miR-181d-5p Protects against Retinal Ganglion Cell Death after Blunt Ocular Injury by Regulating NFIA-Medicated Astrocyte Development.

Authors:  Jinghua Li; Junyi Liu; Yuanping Zhang; Xu Zha; Hong Zhang; Yongying Tang; Xueying Zhao
Journal:  Mediators Inflamm       Date:  2022-10-08       Impact factor: 4.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.